Condition

Alzheimer Disease 1

ClinicalTrials.gov condition label

Clinical trials6

Recruiting0

Common interventions12

Lead sponsors shown6

Clinical trials

6 shown

Brain Health & the MicrobiomeNCT06039267 · 2023-08-25

COMPLETED

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's DiseaseNCT03806478 · 2023-06-01

UNKNOWN

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)NCT05637801 · 2022-12-13

COMPLETED

Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) TherapyNCT05469009 · 2022-07-14

ACTIVE_NOT_RECRUITING

Progress of Mild Alzheimer's Disease in Participants on Acupuncture Versus Sham AcupunctureNCT05078944 · 2022-06-30

COMPLETED

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's DiseaseNCT04100889 · 2020-03-02

WITHDRAWN

Common interventions

Active acupunctureDEVICE1AducanumabDRUG1APH-1105DRUG1Donepezil HydrochlorideDRUG1Exablate Model 4000 Type 2DEVICE1Gut Microbiome TestingOTHER1LecanemabDRUG1No InterventionOTHER1PlaceboOTHER1Sham acupunctureDEVICE1Spectris™ AD - ActiveDEVICE1Spectris™ AD - ShamDEVICE1

Leading sponsors

Ali Rezai1Aphios1Cognito Therapeutics, Inc.1George Washington University1ProgenaBiome1Shanghai Institute of Acupuncture, Moxibustion and Meridian1

Trial status mix

COMPLETED3

ACTIVE_NOT_RECRUITING1

UNKNOWN1

WITHDRAWN1

Phase mix

NA2

EARLY_PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.